Anti-inflammatory effects of a cyclosporine receptor-binding compound, D-43787

Journal of Pharmacology and Experimental Therapeutics

Volumn 301, Issue 2, 2002, Pages 738-746

  Pahl, Andreas ^a,b,c   Zhang, Meixia ^a,b,c   Török, Katalin ^a,b,c   Kuss, Hildegard ^a,b,c   Friedrich, Ute ^a,b,c   Magyar, Zoltan ^a,b,c   Szekely, Jozsef ^a,b,c   Horvath, Katalin ^a,b,c   Brune, Kay ^a,b,c   Szelenyi, Istvan ^a,b,c  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b Institute for Drug Research Budapest   (Hungary)

^c ASTA MEDICA AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

[N [(1 TERT BUTYLOXYCARBONYL)INDOLINE 2 CARBONYL]INDOLINE 2 CARBONACID (NEPSILONBENZYLOXYCARBONYL) 2 LYSINE METHYL ESTER]AMIDE; CALCINEURIN; CD4 ANTIGEN; CYCLOPHILIN; CYCLOSPORIN; CYTOKINE; D 43787; DEXAMETHASONE; DRUG RECEPTOR; GAMMA INTERFERON; IMMUNOSUPPRESSIVE AGENT; INDOMETACIN; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; IONOMYCIN; LIPOPOLYSACCHARIDE; PHORBOL 13 ACETATE 12 MYRISTATE; PHOSPHOPROTEIN PHOSPHATASE; RNA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADJUVANT ARTHRITIS; ALLERGIC ASTHMA; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOSE RESPONSE; DRUG POTENCY; GUINEA PIG; HUMAN; HUMAN CELL; MALE; NONHUMAN; PAW EDEMA; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ARTHRITIS, EXPERIMENTAL; ASTHMA; CELL DIVISION; CYCLOPHILIN A; CYCLOSPORINE; CYTOKINES; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; GUINEA PIGS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INDOLES; INJECTIONS, INTRAPERITONEAL; INJECTIONS, SUBCUTANEOUS; LEUKOCYTES, MONONUCLEAR; LYSINE; MALE; PEPTIDYLPROLYL ISOMERASE; RATS; RATS, INBRED BN; RATS, INBRED LEW; TH1 CELLS; TH2 CELLS;

EID: 18344369348     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.301.2.738     Document Type: Article

References (42)

1. Effect of inhaled cyclosporin A on the allergen-induced late asthmatic response and increased in airway hyperresponsiveness in a guinea pig model of asthma
2. Effects of leukotriene B4 receptor antagonist, LY293111Na, on antigen-induced bronchial hyperresponsiveness and leukocyte infiltration in sensitized guinea pigs
3. Anti-inflammatory actions of glucocorticoids: Molecular mechanisms
4. On steroid-saving drug combinations in carrageenin paw edema and adjuvant arthritis
5. Combination benefit of PEGylated soluble tumor necrosis factor receptor type I (PEG sTNF-RI) and dexamethasone or indomethacin in adjuvant arthritic rats
6. The effect of FK506 and cyclosporin A on antigen-induced arthritis
7. Influence of cyclosporin A on cytokine levels in synovial fluid and serum of rats with antigen-induced arthritis
8. Advances in immunology: Asthma
9. T-helper type 2 cell-directed therapy for asthma
10. Glucocorticoid resistant asthma: T-lymphocyte steroid metabolism and sensitivity to glucocorticoids and immunosuppressive agents
11. Skeletal growth and bone density as sensitive parameters in experimental arthritis: Effect of cyclosporin A
12. Cyclophilin and peptidyl-prolyl cis-trans isomerase are probably identical proteins
13. Effect of acetylsalicylic acid and dexamethasone on antibody production in adjuvant arthritis
14. Immunophilins in protein folding and immunosuppression
15. A novel anti-rheumatic drug suppresses tumor necrosis factor-alpha and augments interleukin-10 in adjuvant arthritic rats
16. Complex pattern of Th1 and Th2 activation with a preferential increase of autereactive Th1 cells in BALB/c mice with proteoglycan (aggrecan)-induced arthritis
17. The role of allergy in the development of asthma
18. Failure of endotoxin-free superoxide dismutase to reduce some paw edemas and adjuvant arthritis in rats
19. Quantitation and kinetics of polymorphonuclear leukocyte and lymphocyte accumulation in joints during adjuvant arthritis in the rat
20. The effect of immunomodulating drugs on adjuvant-induced arthritis in Lewis rats
21. T-cell proliferation involving the CD28 pathway is associated with cyclosporine-resistant interleukin 2 gene expression
22. Attenuation of the allergen-induced late asthmatic reaction by cyclosporin A is associated with inhibition of bronchial eosinophils, interleukin-5, granulocyte macrophage colony-stimulating factor, and eotaxin
23. BCG infection in allergen-presensitized rats suppresses Th2 immune response and prevents the development of allergic asthmatic reaction
24. Calcineurin is a common target of cyclophilin-cyclosporin-A and FKBP-FK506 complexes
25. Double-blind, placebo-controlled study of cyclosporin A as a corticosteroid-sparing agent in corticosteroid-dependent asthma
26. Control of IL-5 production by human helper T cells as a treatment for eosinophilic inflammation: Comparison of in vitro and in vivo effects between selective and nonselective cytokine synthesis inhibitors
27. Chemotherapy of arthritis induced in rats by Mycobacterial adjuvant
28. C-reactive protein as an index of disease activity. Comparison of tenidap, cyclophosphamide and dexamethasone in rat adjuvant arthritis
29. Redirecting Th1 and Th2 responses in autoimmune disease
30. Immunosuppressants: Tools to investigate the physiological role of cytokines
31. The role of lymphocytes in allergic disease
32. Chemistry and biology of the immunophilins and their immunosuppressive ligands
33. Immunophilin-sensitive protein phosphatase action in cell signaling pathways
34. Elevated levels of TNF in the joints of adjuvant arthritic rats
35. Role of circulating inflammatory cytokines in patients during an acute attack of bronchial asthma
36. Temporal expression of inflammatory cytokines and chemokines in rat adjuvant-induced arthritis
37. Analgesic and antiinflammatory effects of dipyrone in rat adjuvant arthritis model
38. Tumour necrosis factor-alpha: The role of this multifunctional cytokine in asthma
39. Treatment of adjuvant arthritis in rats with anti-inflammatory drugs
40. Characterization of T cell subpopulations involved in the pathogenesis of asthma and allergic diseases
41. Sanglifehrin a, a novel cyclophilin-binding compound showing immunosuppressive activity with a new mechanism of action
42. Sanglifehrin A, a novel cyclophilin-binding immunosuppressant, inhibits IL-2-dependent T cell proliferation at the G1 phase of the cell cycle